Lantheus Holdings Appoints Dr Jeffrey Humphrey As Chief Medical Officer and Dr Jean Claude Provost As Chief Science Officer
May 16, 2024•about 1 year ago
Position
Chief Science Officer
Company
Lantheus Holdings
Description
Lantheus Holdings has appointed Dr Jeffrey Humphrey as chief medical officer (CMO) and Dr Jean-Claude Provost as chief science officer (CSO), effective May 28, 2024.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months